Symbol Name ID |
Apoe
apolipoprotein E MGI:88057 |
* | Aspects of the system are reported to show a normal phenotype. |
! | Indicates phenotype varies with strain background. |
Darker colors indicate more annotations |
Human Phenotypes | Increased circulating IgA level |
Increased circulating IgG level |
Decreased circulating antibody level |
Paraproteinemia |
Abnormality of metabolism/homeostasis |
Hypercalcemia |
Hyperbilirubinemia |
Increased LDL cholesterol concentration |
Increased VLDL cholesterol concentration |
Hypercholesterolemia |
Hyperlipidemia |
Hypertriglyceridemia |
Elevated circulating creatinine concentration |
Elevated circulating apolipoprotein A-II concentration |
Elevated circulating apolipoprotein B concentration |
Elevated circulating C-reactive protein concentration |
Hyperproteinemia |
Elevated circulating alanine aminotransferase concentration |
Elevated circulating aspartate aminotransferase concentration |
Glucose intolerance |
Diabetes mellitus |
Type II diabetes mellitus |
Impaired glucose tolerance |
Pleural effusion |
Fever |
Food intolerance |
Abnormality of vitamin B12 metabolism |
Amyloidosis |
Disease(s) Associated with APOE | ||||||||||||||||||||||||||||
atopic dermatitis | ||||||||||||||||||||||||||||
coronary artery disease | ||||||||||||||||||||||||||||
familial combined hyperlipidemia | ||||||||||||||||||||||||||||
malaria | ||||||||||||||||||||||||||||
multiple myeloma | ||||||||||||||||||||||||||||
sea-blue histiocytosis | ||||||||||||||||||||||||||||
Sjogren's syndrome |
Mouse Phenotypes | homeostasis/metabolism phenotype |
decreased cardiac muscle triglyceride level |
increased cholesterol efflux |
decreased circulating homocysteine level |
decreased circulating glucose level |
increased circulating corticosterone level |
decreased circulating insulin level |
decreased circulating leptin level |
abnormal circulating lipid level |
abnormal circulating cholesterol level |
decreased circulating HDL cholesterol level |
increased circulating HDL cholesterol level |
abnormal circulating LDL cholesterol level |
increased circulating LDL cholesterol level |
increased circulating VLDL cholesterol level |
decreased circulating cholesterol level |
increased circulating cholesterol level |
increased circulating phospholipid level |
decreased circulating triglyceride level |
increased circulating triglyceride level |
hyperlipidemia |
abnormal circulating protein level |
abnormal circulating apolipoprotein E level |
abnormal glomerular capillary thrombosis |
abnormal nitric oxide homeostasis |
improved glucose tolerance |
increased insulin sensitivity |
abnormal lipid homeostasis |
abnormal cholesterol homeostasis |
decreased liver cholesterol level |
decreased cholesterol level |
increased cholesterol level |
abnormal lipid level |
increased prostaglandin level |
decreased liver triglyceride level |
decreased skeletal muscle triglyceride level |
decreased triglyceride level |
increased triglyceride level |
xanthoma |
abnormal enzyme/coenzyme activity |
abnormal nucleotide metabolism |
decreased cerebral infarct size |
|
Availability | Mouse Genotype | ||||||||||||||||||||||||||||||||||||||||||
Apoeshl/Apoeshl | ! | ! | |||||||||||||||||||||||||||||||||||||||||
ApoeTg(rtTA)1Gaga/ApoeTg(rtTA)1Gaga | |||||||||||||||||||||||||||||||||||||||||||
Apoetm1.1Khw/Apoetm1.1Khw | * | ||||||||||||||||||||||||||||||||||||||||||
Apoetm1Bres/Apoetm1Bres | |||||||||||||||||||||||||||||||||||||||||||
Apoetm1Khw/Apoetm1Khw | |||||||||||||||||||||||||||||||||||||||||||
Apoetm1Lmh/Apoetm1Lmh | |||||||||||||||||||||||||||||||||||||||||||
Apoetm1Unc/Apoetm1Unc | |||||||||||||||||||||||||||||||||||||||||||
Apoetm1Unc/Apoetm1Unc Tg(Cyp21a1-Apoe)614Fet/0 |
|||||||||||||||||||||||||||||||||||||||||||
Apoetm1Unc/Apoetm1Unc Tg(Cyp21a1-Apoe)619Fet/0 |
|||||||||||||||||||||||||||||||||||||||||||
Apoetm4Mae/Apoetm4Mae | |||||||||||||||||||||||||||||||||||||||||||
Apoeshl/Apoetm1Unc | |||||||||||||||||||||||||||||||||||||||||||
Apoetm1Bres/Apoe+ | |||||||||||||||||||||||||||||||||||||||||||
Apoetm1Lmh/Apoe+ | |||||||||||||||||||||||||||||||||||||||||||
Apoetm1Unc/Apoe+ | |||||||||||||||||||||||||||||||||||||||||||
Tg(Cyp21a1-Apoe)614Fet/0 | |||||||||||||||||||||||||||||||||||||||||||
Tg(Cyp21a1-Apoe)619Fet/0 | |||||||||||||||||||||||||||||||||||||||||||
Apoetm1.1Mae/Apoetm1.1Mae Tg(Fabp4-cre)1Rev/0 (conditional) |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/16/2024 MGI 6.23 |
|
|